About Collateral Therapeutics
Collateral Therapeutics, based in San Diego, focuses on industrial goods and manufacturing, and manufacturing services. Provider of geomembrane welding equipments. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarter San Diego, United States
-
Sectors
Industrial Goods & Manufacturing
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Collateral Therapeutics
Detailed funding history for Collateral Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Collateral Therapeutics
Collateral Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bayer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science solutions for healthcare and agriculture are delivered.
|
Locked | Locked | Locked |
Investor details for Collateral Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Collateral Therapeutics
Investment portfolio details for Collateral Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Collateral Therapeutics
Detailed financials for Collateral Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Collateral Therapeutics Comparisons
Peer comparison for Collateral Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Collateral Therapeutics
Detailed competitors of Collateral Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Collateral Therapeutics
Complete news archive for Collateral Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Collateral Therapeutics
Collateral Therapeutics was founded in 2020.
Collateral Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Collateral Therapeutics, based in San Diego, focuses on industrial goods and manufacturing, and manufacturing services. Provider of geomembrane welding equipments. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Collateral Therapeutics has 1 investor. Key investors include Bayer.